Total Payments
$2,105
2024 Payments
$319.66
Companies
15
Transactions
128
Medicare Patients
8,145
Medicare Billing
$16.1M
Payment Breakdown by Category
Food & Beverage$2,085 (99.0%)
Education$20.08 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,085 | 127 | 99.0% |
| Education | $20.08 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $650.23 | 49 | $0 (2024) |
| Amgen Inc. | $463.30 | 28 | $0 (2024) |
| Janssen Biotech, Inc. | $282.17 | 15 | $0 (2023) |
| GlaxoSmithKline, LLC. | $113.73 | 7 | $0 (2022) |
| Horizon Therapeutics plc | $99.66 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $99.38 | 6 | $0 (2020) |
| PFIZER INC. | $93.01 | 5 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $70.92 | 2 | $0 (2023) |
| Lilly USA, LLC | $62.12 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $48.91 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $319.66 | 23 | ABBVIE INC. ($292.66) |
| 2023 | $369.12 | 22 | AbbVie Inc. ($142.37) |
| 2022 | $465.01 | 25 | ABBVIE INC. ($142.89) |
| 2021 | $282.37 | 15 | Amgen Inc. ($70.03) |
| 2020 | $347.44 | 26 | Amgen Inc. ($136.53) |
| 2019 | $178.29 | 10 | Amgen Inc. ($50.04) |
| 2018 | $142.70 | 7 | Janssen Biotech, Inc. ($38.46) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: IMMUNOLOGY | ||||||
| 04/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: IMMUNOLOGY | ||||||
| 01/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 01/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,085 | 733,702 | $10.7M | $4.3M |
| 2022 | 27 | 2,125 | 674,740 | $9.6M | $4.0M |
| 2021 | 28 | 1,995 | 620,250 | $9.4M | $4.3M |
| 2020 | 29 | 1,940 | 414,127 | $7.7M | $3.5M |
Total Patients
8,145
Total Services
2,442,819
Medicare Billing
$16.1M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 93 | 409,355 | $3.7M | $1.9M | 50.8% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 89 | 270,800 | $2.7M | $1.1M | 39.0% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 37 | 12,833 | $1.6M | $328,666 | 21.0% |
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 16 | 4,300 | $657,900 | $272,496 | 41.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 24 | 20,300 | $791,700 | $213,031 | 26.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 97 | 10,380 | $284,400 | $189,690 | 66.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 629 | 1,447 | $264,801 | $130,500 | 49.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 156 | 1,043 | $347,319 | $105,490 | 30.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 97 | 1,364 | $216,264 | $78,455 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 141 | 227 | $57,885 | $30,080 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 144 | 144 | $34,128 | $15,372 | 45.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 55 | 359 | $26,566 | $7,844 | 29.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 45 | 92 | $22,272 | $6,610 | 29.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 28 | 101 | $14,948 | $5,015 | 33.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $9,048 | $4,834 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 50 | $6,450 | $3,200 | 49.6% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 57 | 94 | $8,648 | $3,047 | 35.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 233 | $8,388 | $2,587 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,293 | $2,302 | 53.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 24 | 130 | $6,630 | $1,545 | 23.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 44 | 69 | $822.00 | $417.54 | 50.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 38 | $456.00 | $227.08 | 49.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 38 | $1,406 | $224.26 | 16.0% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 16 | 43 | $516.00 | $183.65 | 35.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 12 | 36 | $684.00 | $165.79 | 24.2% |
About Dr. David Carleton, MD
Dr. David Carleton, MD is a Rheumatology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508073644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Carleton, MD has received a total of $2,105 in payments from pharmaceutical and medical device companies, with $319.66 received in 2024. These payments were reported across 128 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,085).
As a Medicare-enrolled provider, Carleton has provided services to 8,145 Medicare beneficiaries, totaling 2,442,819 services with total Medicare billing of $16.1M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Richmond, VA
- Active Since 05/17/2007
- Last Updated 12/23/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1508073644
Products in Payments
- RINVOQ (Biological) $375.50
- Enbrel (Biological) $279.35
- SKYRIZI (Biological) $244.81
- REMICADE (Biological) $177.62
- BENLYSTA (Biological) $113.73
- KRYSTEXXA (Biological) $100.66
- ORENCIA (Biological) $99.38
- TREMFYA (Drug) $72.03
- EVENITY (Biological) $71.16
- ACTHAR (Biological) $70.92
- Rituxan (Biological) $47.79
- XELJANZ (Drug) $47.16
- INFLECTRA (Biological) $45.85
- Tavneos (Drug) $42.44
- TALTZ (Drug) $42.43
- SIMPONI ARIA (Biological) $32.52
- ILARIS (Drug) $31.55
- Cimzia (Drug) $22.60
- TAVNEOS (Drug) $21.76
- Hymovis (Device) $21.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Richmond
Dr. Michael Strachan, M.d, M.D
Rheumatology — Payments: $299,200
Rheumatology $299,200
Dr. Karim Masri, M.d, M.D
Rheumatology — Payments: $220,639
Rheumatology $220,639
Tammy Spring, M.d, M.D
Rheumatology — Payments: $18,871
Rheumatology $18,871
Dr. Mihail Moroianu, M.d, M.D
Rheumatology — Payments: $16,532
Rheumatology $16,532
Dr. Peter Coutlakis, M.d, M.D
Rheumatology — Payments: $13,961
Rheumatology $13,961
Dr. Avnit Ahuja, Md, MD
Rheumatology — Payments: $9,294
Rheumatology $9,294